SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011988
Filing Date
2024-08-13
Accepted
2024-08-13 09:22:04
Documents
80
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q elut-20240630x10q.htm   iXBRL 10-Q 2105784
2 EX-31.1 elut-20240630xex31d1.htm EX-31.1 15127
3 EX-31.2 elut-20240630xex31d2.htm EX-31.2 15095
4 EX-32.1 elut-20240630xex32d1.htm EX-32.1 6772
5 EX-32.2 elut-20240630xex32d2.htm EX-32.2 6712
  Complete submission text file 0001558370-24-011988.txt   8876550

Data Files

Seq Description Document Type Size
6 EX-101.SCH elut-20240630.xsd EX-101.SCH 63412
7 EX-101.CAL elut-20240630_cal.xml EX-101.CAL 50436
8 EX-101.DEF elut-20240630_def.xml EX-101.DEF 300523
9 EX-101.LAB elut-20240630_lab.xml EX-101.LAB 568606
10 EX-101.PRE elut-20240630_pre.xml EX-101.PRE 447144
83 EXTRACTED XBRL INSTANCE DOCUMENT elut-20240630x10q_htm.xml XML 1436845
Mailing Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904
Business Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 240-247-1143
ELUTIA INC. (Filer) CIK: 0001708527 (see all company filings)

IRS No.: 474790334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39577 | Film No.: 241199095
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)